Literature DB >> 11506195

Role of adhesion molecules in activation signaling in T lymphocytes.

M L Dustin1.   

Abstract

The T cell and antigen-presenting cell communicate to initiate an immune response through formation of an immunological synapse. This specialized cell-cell junction is compartmentalized into adhesion molecule and T cell receptor enriched regions or SMACs. Distinct signals seem to be generated in the T cell receptor and adhesion molecule-dominated regions. This review focuses on how these distinct signaling pathways may be integrated within the T cell to set thresholds for T cell activation, proliferation, and survival.

Mesh:

Substances:

Year:  2001        PMID: 11506195     DOI: 10.1023/a:1010927208180

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  45 in total

1.  TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1.

Authors:  K G Johnson; F G LeRoy; L K Borysiewicz; R J Matthews
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

Review 2.  Signaling takes shape in the immune system.

Authors:  M L Dustin; A C Chan
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

3.  Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells.

Authors:  D Fang; H Y Wang; N Fang; Y Altman; C Elly; Y C Liu
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

4.  Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential.

Authors:  M Gunzer; A Schäfer; S Borgmann; S Grabbe; K S Zänker; E B Bröcker; E Kämpgen; P Friedl
Journal:  Immunity       Date:  2000-09       Impact factor: 31.745

Review 5.  T cell differentiation: a mechanistic view.

Authors:  O Avni; A Rao
Journal:  Curr Opin Immunol       Date:  2000-12       Impact factor: 7.486

6.  Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes.

Authors:  D F Kucik; M L Dustin; J M Miller; E J Brown
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

Review 7.  Regulation of T cell activation by CD28 and CTLA4.

Authors:  P J Noel; L H Boise; C B Thompson
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

8.  Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vav1.

Authors:  C K Miranti; L Leng; P Maschberger; J S Brugge; S J Shattil
Journal:  Curr Biol       Date:  1998-12-03       Impact factor: 10.834

9.  Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction.

Authors:  B M Burgering; P J Coffer
Journal:  Nature       Date:  1995-08-17       Impact factor: 49.962

10.  Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity.

Authors:  E Bianchi; S Denti; A Granata; G Bossi; J Geginat; A Villa; L Rogge; R Pardi
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

View more
  15 in total

1.  Antigen-independent adhesion and cell spreading by inducible costimulator engagement inhibits T cell migration in a PI-3K-dependent manner.

Authors:  Jennifer L Franko; Alan D Levine
Journal:  J Leukoc Biol       Date:  2008-12-18       Impact factor: 4.962

Review 2.  GVHD: a continuing barrier to the safety of allogeneic transplantation.

Authors:  Pavan Reddy; Mukta Arora; Martin Guimond; Crystal L Mackall
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

3.  The ADAP/SKAP55 signaling module regulates T-cell receptor-mediated integrin activation through plasma membrane targeting of Rap1.

Authors:  Stefanie Kliche; Dennis Breitling; Mauro Togni; Rico Pusch; Katja Heuer; Xiaoqian Wang; Christian Freund; Ana Kasirer-Friede; Gael Menasche; Gary A Koretzky; Burkhart Schraven
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

Review 4.  State-of-the-art acute and chronic GVHD treatment.

Authors:  Muhammad Omer Jamil; Shin Mineishi
Journal:  Int J Hematol       Date:  2015-04-12       Impact factor: 2.490

5.  CEACAM1 in cervical cancer and precursor lesions: association with human papillomavirus infection.

Authors:  Benibelks Albarran-Somoza; Ramon Franco-Topete; Vidal Delgado-Rizo; Felipe Cerda-Camacho; Lourdes Acosta-Jimenez; Miguel Lopez-Botet; Adrian Daneri-Navarro
Journal:  J Histochem Cytochem       Date:  2006-08-21       Impact factor: 2.479

Review 6.  Current and future approaches for control of graft-versus-host disease.

Authors:  John Koreth; Joseph H Antin
Journal:  Expert Rev Hematol       Date:  2008-10       Impact factor: 2.929

Review 7.  Paving the way towards universal treatment with allogenic T cells.

Authors:  Michelle H Townsend; Kelsey Bennion; Richard A Robison; Kim L O'Neill
Journal:  Immunol Res       Date:  2020-02       Impact factor: 2.829

Review 8.  Graft-versus-host disease.

Authors:  James L M Ferrara; John E Levine; Pavan Reddy; Ernst Holler
Journal:  Lancet       Date:  2009-03-11       Impact factor: 79.321

9.  Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).

Authors:  Yvonne A Efebera; Susan Geyer; Leslie Andritsos; Sumithira Vasu; Samantha Jaglowski; Anissa Bingman; William Blum; Rebecca Klisovic; Craig C Hofmeister; Don M Benson; Sam Penza; Patrick Elder; Katie Cortright; Rhonda Kitzler; Kevin Coombes; Lynn O'Donnell; Beth Daneault; Hillary Bradbury; Jianying Zhang; Xilin Chen; Sabrina Garman; Parvathi Ranganathan; Xueyan Yu; Jessica Hofstetter; Jianhua Yu; Ramiro Garzon; Scott R Scrape; Gerard Lozanski; Steven M Devine
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-06       Impact factor: 5.742

Review 10.  Pathophysiology of acute graft-versus-host disease: recent advances.

Authors:  Yaping Sun; Isao Tawara; Tomomi Toubai; Pavan Reddy
Journal:  Transl Res       Date:  2007-07-03       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.